GlassScriptPhysician profile
Ayub Mwaura
NPI 1780354944
$6,534.49
in general payments reported to CMS, 2019-2025
6 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $6,067 · 2024: $28.62 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Consulting Fee: $3,000 · Food and Beverage: $354 · Education: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Consulting Fee | $3,000.00 |
| Food and Beverage | $353.51 |
| Education | $180.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainsway USA INC | $6,000.00 | 2023 | Brainsway Deep Tms |
| Teva Pharmaceuticals USA, INC. | $375.54 | 2025 | Austedo Xr |
| Axsome Therapeutics, INC. | $66.73 | 2023 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $37.93 | 2025 | Cobenfy |
| Lundbeck LLC | $28.62 | 2024 | Rexulti |
| Vanda Pharmaceuticals INC. | $25.67 | 2025 | Fanapt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayub Mwaura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.